Atlas Trials

Refractory Central Nervous System Tumor

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Central Nervous System Tumor

RecordFirmDate
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma (NCT03690869)Regeneron Pharmaceuticals2018-09-24

Track Refractory Central Nervous System Tumor automatically

Every clearance here is in the API, with alerts when new ones post.